tcb008
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2021 (NCT04834128)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06463327 | Phase 1 | Jan 31, 2025 | TC Biopharm |
| NCT05358808 | Phase 2 | May 31, 2022 | TC Biopharm |
| NCT04834128 | Phase 2 | Aug 1, 2021 | TC Biopharm |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TC Biopharm | For profit | 3 | 3 | 2 | 2021 |
1 organizations
Page 1 / 1